Lipophilic N-substituted norcantharimide derivatives and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9359373
APP PUB NO 20160145264A1
SERIAL NO

14550490

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel N-substituted norcantharimide derivatives are disclosed herein. The novel N-substituted norcantharimide derivatives are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating cancer, particularly for treating leukemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAIPEI VETERANS GENERAL HOSPITALNO 201 SEC 2 SHIPAI RD BEITOU DISTRICT TAIPEI CITY 112

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Yu-Jen Taipei, TW 328 929
Kuo, Cheng-Deng Taipei, TW 5 103
Liao, Hui-Fen Chiayi, TW 8 20
Wu, Jin-Yi Chiayi, TW 5 104

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00